ELYM Old Performance
| ELYMDelisted Stock | USD 3.09 0.06 1.90% |
The firm shows a Beta (market volatility) of -0.0301, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ELYM Old are expected to decrease at a much lower rate. During the bear market, ELYM Old is likely to outperform the market. At this point, ELYM Old has a negative expected return of -0.81%. Please make sure to confirm ELYM Old's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if ELYM Old performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ELYM Old has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 43.6 M |
ELYM |
ELYM Old Relative Risk vs. Return Landscape
If you would invest 392.00 in ELYM Old on October 30, 2024 and sell it today you would lose (83.00) from holding ELYM Old or give up 21.17% of portfolio value over 90 days. ELYM Old is currently does not generate positive expected returns and assumes 4.6176% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than ELYM, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ELYM Old Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ELYM Old's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ELYM Old, and traders can use it to determine the average amount a ELYM Old's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1749
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ELYM |
Estimated Market Risk
| 4.62 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.81 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ELYM Old is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ELYM Old by adding ELYM Old to a well-diversified portfolio.
ELYM Old Fundamentals Growth
ELYM Stock prices reflect investors' perceptions of the future prospects and financial health of ELYM Old, and ELYM Old fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ELYM Stock performance.
| Return On Equity | -0.38 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | 23.84 M | |||
| Shares Outstanding | 67.06 M | |||
| Price To Book | 0.99 X | |||
| EBITDA | (13.65 M) | |||
| Cash And Equivalents | 122.95 M | |||
| Cash Per Share | 4.63 X | |||
| Total Debt | 349 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 3.33 X | |||
| Cash Flow From Operations | (20.6 M) | |||
| Earnings Per Share | (2.22) X | |||
| Total Asset | 110.47 M | |||
| Retained Earnings | (155.98 M) | |||
About ELYM Old Performance
By examining ELYM Old's fundamental ratios, stakeholders can obtain critical insights into ELYM Old's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ELYM Old is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.Things to note about ELYM Old performance evaluation
Checking the ongoing alerts about ELYM Old for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ELYM Old help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ELYM Old is now traded under the symbol CLYM. Please update your portfolios or report it if you believe this is an error. Report It! | |
| ELYM Old is not yet fully synchronised with the market data | |
| ELYM Old generated a negative expected return over the last 90 days | |
| ELYM Old has high historical volatility and very poor performance | |
| ELYM Old has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.12 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ELYM Old currently holds about 122.95 M in cash with (20.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.63, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 78.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ELYM Old's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ELYM Old's stock is overvalued or undervalued compared to its peers.
- Examining ELYM Old's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ELYM Old's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ELYM Old's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ELYM Old's stock. These opinions can provide insight into ELYM Old's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in ELYM Stock
If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |